Morbid obesity
Conditions
Interventions
Intragastric balloon therapy
Sponsors
Division of Gastroenterology and Hepatology, University of Tsukuba Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Morbid obese subjects resistant to long-term (more than 6 months) medical treatments, such as diet, exercise, and behavior. 2.Morbid obese subjects in which the complications associted with obesity can be expected to improve by weight reduction. 3.Morbid obese subjects who can be followed up for at least 6 months after the start of intragastric balloon therapy. 4.Morbid obese subjects in which no abnormal lesions are found by upper alimentary tract endoscopy.
Exclusion criteria
Exclusion criteria: 1.Morbid obese subjects with severe heart and lung disorders. 2.Morbid obese subjects with esophageal hiatus hernia. 3.Morbid obese subjects with inflammatory disorders in the alimentary tracts. 4.Morbid obese subjects with bleeding tendency. 5.Morbid obese subjects during pregnancy and those nursing a baby. 6.Morbid obese subjects who cannnot understand the meaning of intragastric balloon therapy and continue the therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight reduction induced by intragastric balloon therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in body composition, metabolic function, oxidative stress markers, and hepatic steatosis | — |
Countries
Japan
Contacts
Public ContactJunichi Shoda
University of Tsukuba Hospital Gastroenterology and Hepatology
Outcome results
None listed